Authors interested in presenting an abstract in a mini-symposium are invited to contact the organisers. Contact details can be found on each proposal.

For submission of abstracts, please refer to the instructions given here.

* indicates the name of the main contact person (or organiser)

Organisers: Jichao Pan*, Ningbo University, China (Email: panjichao@nbu.edu.cn); Jiaqiu Wang, London South Bank University, United Kingdom; Zhiyong Li, Queensland University of Technology, Australia.

Keywords: Cardiovascular biomechanics, Multiscale modelling, Mechanobiology, Cross-scale coupling.

Relevant Conference Topics: Cardiovascular modelling, Multiscale modelling, Multiphysics modelling

Mini-symposium details:

BACKGROUND
Cardiovascular diseases arise from dynamic interactions between mechanical, biochemical, and cellular processes that span multiple spatial and temporal scales. These multiscale processes contribute to both pathological progression and post-intervention adaptation of cardiovascular tissues. At organ and tissue scales, haemodynamics, cardiac and vascular mechanics, and fluid-structure interactions determine the mechanical loading and functional state of the system. At cellular and microenvironmental scales, transport, biochemical signalling, and cellular processes govern changes in composition and function, while extracellular matrix turnover and other structural responses further modify material properties and contribute to remodelling. These processes are coupled through bidirectional feedback: haemodynamic and mechanical cues influence microenvironmental and cellular responses, which in turn alter structural and material properties, feeding back on organ-level mechanics and function.

Recent advances in mathematical and computational modelling have enabled increasingly detailed descriptions of cardiovascular processes at different scales. An important next step is to integrate these descriptions across scales so that the coupled mechanisms underlying pathological evolution and post-intervention adaptation can be investigated within a unified framework. Multiscale modelling provides a basis for this integration by linking cellular and microenvironmental processes with tissue- and organ-level mechanics and function.

SCOPE AND PURPOSE
This mini-symposium will bring together researchers in cardiovascular biomechanics, mathematical modelling, mechanobiology, and computational mechanics to advance understanding of cardiovascular disease progression and post-intervention adaptation across scales. Particular emphasis will be placed on frameworks that connect organ- and tissue-level haemodynamics and mechanics with mechanochemical processes, cellular dynamics, and tissue adaptation across spatial and temporal scales. Mechanistic and computational approaches for cross-scale integration will be highlighted, spanning PDE-based and multiphysics modelling, discrete-continuum coupling, and physics-based reduced-order or surrogate models, together with experimental and data-informed strategies that support model development, calibration, and validation.

TOPICS COVERED
The symposium welcomes contributions on topics including, but not limited to:
1. Multiscale mechanisms of cardiovascular disease progression, exploring the initiation, evolution, and remodelling of cardiovascular pathologies across cardiac and vascular tissues, including mechanical, biochemical, and cellular processes.
​2. Post-intervention cardiovascular adaptation and remodelling, spanning device-based, pharmacological, surgical, and physical interventions, with emphasis on mechanical and haemodynamic responses, subsequent biological adaptation, and longer-term remodelling.
3. Cross-scale coupling and feedback in cardiovascular adaptation, addressing interactions among haemodynamics, tissue mechanics, transport and signalling, cellular behaviour across spatial and temporal scales that collectively alter tissue-level dynamics.
4. Mathematical and computational frameworks for multiscale cardiovascular modelling, covering PDE-based and multiphysics formulations, discrete-continuum approaches, multiscale numerical methods, reduced-order modelling, and physics-based surrogate models.
5. Experimental and data-informed multiscale modelling, integrating imaging, experimental and clinical data with parameter inference, model calibration and validation, uncertainty quantification, and mechanistic interpretation.

Organisers: Elena Zappon, Gottfried Schatz Research Center: Medical Physics and Biophysics, Medical University of Graz, Austria; Irène Vignon-Clementel, Inria; Anna Ranno, Chair for Computational Analysis of Technical Systems (CATS), RWTH Aachen University, Germany; Guadalupe García Isla, Center for Research and Innovation in Bioengineering (Ci2B), Universitat Politècnica de València, Spain; Ludovica Cicci, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, United Kingdom; Federica Caforio*, Department of Mathematics and Scientific Computing, University of Graz, Austria (Email: federica.caforio@uni-graz.at).

Keywords: Cardiovascular modeling, Hybrid mechanistic and data-driven methods, Surrogate modelling, VVUQ.

Relevant Conference Topics: Cardiovascular modelling, Computational medicine, Artificial intelligence (AI) and machine learning, Digital twins

Mini-symposium details:

BACKGROUND
Cardiovascular disease remains a leading cause of morbidity and mortality worldwide. Computational modelling is increasingly central to understanding its progression and guiding treatment. Multiphysics and multiscale approaches couple cardiac electrophysiology and mechanics with coronary and systemic haemodynamics. Their applications span a broad range of cardiovascular diseases and interventions, from cardiac dysfunction to atherosclerosis and thrombosis, including the prediction of disease progression, treatment planning and outcome (e.g., cardiac ablation, vascular stenting, flow-diverter implantation).
Advances in physics-based modelling and numerical methods are enhancing the accuracy, computational efficiency, and robustness of simulations. In parallel, the integration of patient-specific imaging and clinical measurements enables the development of cardiac and vascular digital twins, virtual cohorts, and clinically relevant predictive models, bringing computational modelling closer to personalised and translational medicine. Yet clinical translation demands models that are not only accurate but also capable of real-time predictions and personalisable at scale. In recent years, hybrid modelling paradigms that combine mechanistic models with statistical and machine learning approaches have increasingly been developed and adopted. Reduced-order models, neural operators, and physics-aware architectures provide efficient surrogates for computationally expensive forward solvers, while data assimilation and generative methods facilitate model calibration and inference from sparse and noisy clinical and imaging data.
Collectively, these advances are paving the way towards cardiovascular digital twins capable of continuously learning and updating from multimodal, patient-specific data. Nevertheless, significant challenges remain in quantifying uncertainty, validating model predictions, reducing computational cost to enable real-time use, and establishing the credibility required for clinical and industrial adoption.

SCOPE AND PURPOSE
This mini-symposium brings together applied mathematicians and biomedical engineers developing computational and data-driven methods for cardiovascular modelling and digital twinning. It aims to connect methodological advances in computational modelling, reduced-order modelling, machine learning and uncertainty quantification with their calibration, validation and eventual translation into clinical practice and industrial R&D applications, stimulating discussion of open challenges and new collaborations within the international community.

TOPICS COVERED
1. Statistic-based and machine-learning based mathematical methods for generation of mesh-ready anatomical models, and virtual cohort of anatomies.
​2. Methodologies for data-assimilation, including experimental, multimodal imaging, or clinical data within cardiovascular modelling for the development of digital twinning strategies.
3. Reduced-order and data-driven methods for surrogate modelling and real-time and population-scale simulation.
4. Hybrid-mechanistic-data-driven modelling approaches, Bayesian inference and generative models for computational model calibration, predictive modeling, and clinical decision support.
5. Simulation-supported treatment of cardiovascular diseases (e.g., device design and intervention planning), including optimisation and pre-clinical evaluation.
6. Verification, validation and uncertainty quantification (VVUQ) for clinical credibility.

Organisers: Yang Zhang, School of Physics, Nanjing University of Science and Technology, Nanjing, China; Anqiang Sun, School of Biological Science and Medical Engineering, Beihang University, Beijing, China; Jorge Molina, University of Las Palmas de Gran Canaria, Escuela de Ingenieros Industriales y Civiles, Campus Universitario de Tafira, 35014 Las Palmas de Gran Canaria, Spain; Adesola Ademiloye*, Department of Biomedical Engineering, Swansea University, Swansea, United Kingdom (Email: a.s.ademiloye@swansea.ac.uk).

Keywords: numerical methods, artificial intelligence, multiphysics and multifield phenomena, finite element and meshfree methods.

Relevant Conference Topics: Multiscale modelling, Computational medicine, Artificial intelligence (AI) and machine learning, Numerical methods

Mini-symposium details:

INTRODUCTION
The aim of this mini-symposium is to create a unified platform where engineers, mechanicians, applied mathematicians and data scientists can exchange ideas and discuss recent advancements in classical numerical methods, data-driven models and their hybrids for biomedical engineering applications. In recent decades, there has been a significant increase in the development and application of advanced numerical methods in computational biomedical engineering. These methods offer increased flexibility in tackling complex patient-specific problems, notably with meshfree methods effectively addressing limitations inherent in mesh-based techniques when dealing with issues of large deformations and complex geometries, often encountered in computational biomechanics. More recently, physics-informed machine learning (including PINNs, neural ODEs and neural operators), hybrid PDE-ML frameworks, and probabilistic numerics have begun to complement classical solvers, enabling rapid inference, inverse modelling, data assimilation and uncertainty quantification in data-scarce and high-dimensional biomedical settings.

Additionally, the biomedical engineering areas of interest can span multiple scales in length and time, as well as different physics and fields, and increasingly needing the integration of mechanistic modelling with machine learning and data-centric approaches. We are particularly interest in the development of new numerical framework to tackle complex biomedical engineering problems involving cells (like red blood cells), soft tissues (such as lung and skin), hard tissues (e.g., bones and teeth), organs (such as the heart and brain), arteries, microcapillaries, tissue growth, morphogenesis, patient-specific treatments, targeted drug delivery, and digital twins for personalised medicine.

SCOPE OF THE MINISYMPOSIUM
Contributions in the following areas are especially encouraged:
– Development of Novel Algorithms: Creation of new algorithms and frameworks to improve the accuracy, efficiency and scalability of classical and data-driven numerical methods, including molecular dynamics, meshfree and particle methods, virtual elements, finite elements, phase-field methods, physics-informed neural networks, neural operators and graph-based surrogates, for solving biomedical problems at cellular, tissue, organ and system levels.
– Innovative Applications in Computational Biomechanics: Pioneering applications of these numerical and data-driven methods in computational biomechanics, particularly in biosolid and biofluid mechanics, patient-specific haemodynamics, turbulence and transitional flows in cardiovascular systems, and fluid-structure interaction in heart valves, airways and soft tissues.
– Computational Modelling of Coupled Phenomena: Exploration of computational models for coupled multiphysics and multifield phenomena in biomedical engineering and biomechanics, including hybrid mechanistic-data-driven models of growth and remodelling, electrophysiology, transport and reaction-diffusion processes, and mechano-chemical coupling in tissues and tumours.
– Advanced Numerical Methods for Multiscale Linking: Advancement of numerical and machine learning-based methods to bridge mechanics and biology across scales, from subcellular and cellular to tissue, organ and system levels, integrating imaging, experimental data, single-cell measurements and mechanistic constraints, and supporting dimensionless modelling and law discovery from sparse data.
– Experimental and Clinical Validation: Investigation of experimental and clinical validation of numerical and data-driven methods, together with the integration of artificial intelligence techniques, including uncertainty quantification, calibration, data assimilation (e.g. particle filters and ensemble Kalman methods), and digital-twin workflows for prediction, monitoring and control in clinical contexts.

This mini-symposium is particularly suitable for researchers in computational mechanics with an interest in biomedical applications, as well as those developing or applying data-driven, physics-informed and hybrid models in biomedicine. It aims to foster a comprehensive understanding of these advanced numerical and learning-based tools and to highlight their role in enhancing biomedical engineering solutions across a wide range of domains and applications.

Organisers: Lizhen Wang, Key Laboratory of Biomechanics and Mechanobiology of Ministry of Education, Beijing Advanced Innovation Center for Biomedical Engineering, School of Biological Science and Medical Engineering, Beihang University, China; Debao Guan*, School of Control Science and Engineering, Shandong University, China (Email: debao.guan@sdu.edu.cn); Hao Gao, School of Mathematics and Statistics, University of Glasgow, UK.

Keywords: Soft Tissue Mechanics, Personalized Modelling, Artificial Intelligence, Injury prevention.

Relevant Conference Topics: Cardiovascular modelling, Constitutive modelling – soft and hard tissues, Biofluid and biosolid mechanics, Medical devices and implants

Mini-symposium details:

BACKGROUND

Biomechanics plays a critical role in understanding the complex interactions between biological structures, mechanical environments, and human health. Recent advances in computational mechanics, medical imaging, and artificial intelligence (AI) have significantly expanded the capability of biomechanical modelling from fundamental tissue characterization toward personalized prediction, intelligent decision-making, and clinical translation. Important applications include cardiovascular biomechanics, musculoskeletal biomechanics, injury prevention, and rehabilitation engineering, all of which involve complex interactions between biological tissues, mechanical loading, and physiological function. These emerging approaches are providing new opportunities for developing adaptive systems that can interact intelligently with the human body and support healthcare applications.

SCOPE AND PURPOSE

This mini-symposium aims to provide an interdisciplinary forum for researchers working in soft tissue biomechanics, personalized computational modelling, injury prevention, and rehabilitation engineering. Particular emphasis will be placed on emerging approaches that integrate physics-based modelling, medical imaging, artificial intelligence, data-driven methods, and experimental or clinical data to enhance prediction, diagnosis, intervention, and rehabilitation.

TOPICS COVERED
The mini-symposium will cover, but is not limited to, the following topics:

1. Soft Tissue Mechanics and Constitutive Modelling
Development, calibration, and validation of constitutive models for biological soft tissues using experimental, imaging, and clinical data; modelling of tissue adaptation, growth, remodelling, damage, and failure mechanisms.

2. Personalized in-Silico and Multiphysics Biomechanics
Patient-specific computational modelling, digital twins, image-based model construction, uncertainty quantification, and multiphysics simulations involving fluid-structure interaction, cardiac electromechanics, blood flow, and transport phenomena.

3. Injury Prevention and Protection Biomechanics
Computational and experimental investigation of injury mechanisms under impact, repetitive loading, and movement conditions; development and evaluation of protective systems, medical devices, and biomechanical risk-assessment frameworks.

4. Rehabilitation Engineering and Human Movement Biomechanics
Biomechanical analysis of rehabilitation processes, recovery assessment, assistive technologies, musculoskeletal modelling, human movement analysis, wearable sensing, and personalized rehabilitation strategies.

5. AI-enabled Biomechanics and Intelligent Healthcare Systems
Physics-informed artificial intelligence, machine learning, surrogate modelling, parameter inference, data assimilation, uncertainty-aware prediction, automated medical image analysis, and AI-enabled decision support for biomechanical and healthcare applications.

By bringing together researchers from computational mechanics, biomedical engineering, and artificial intelligence, this mini-symposium will promote new collaborations and accelerate the translation of biomechanical modelling and intelligent healthcare technologies into practical clinical and engineering applications.

Organisers: Mette Olufsen, Department of Mathematics, North Carolina State University, United States of America; Mitchel Colebank*, Department of Mathematics, University of South Carolina, Columbia, United States of America (Email: mjcolebank@sc.edu).

Keywords: Cardiovascular, Uncertainty Quantification, Inference, Digital Twin.

Relevant Conference Topics: Cardiovascular modelling, Data-driven modelling for biomedical applications, Digital twins, Uncertainty quantification

Mini-symposium details:

BACKGROUND: Modeling and simulation forms a foundation for cardiovascular digital shadow and digital twin development. A key part of these pipelines includes the inverse problem, which requires data integration across modalities like imaging, non-invasive and invasive measurements, and vital monitoring. Consistent integration of this data with simulators requires systematic analysis of the model systems conditioned on available, noisy data, inviting the use of sensitivity and identifiability analyses, dimension reduction, surrogate modeling, and uncertainty quantification.

SCOPE AND PURPOSE: This minisymposium will provide cutting edge examples of these analysis methods in the development of cardiovascular digital shadows or twins. This includes calibration to synthetic data, clinical/animal data, data assimilation, and forecasting for human-in-the-loop decision making.

TOPICS COVERED: Examples of content in this minisymposium include (but not limited to):
– Novel methods for assessing parameter identifiability
– Emulation strategies, including scientific-machine learning
– New sensitivity analysis methods for screening non-influential parameters
– Robust data assimilation frameworks for rapid calibration and forecasting
– Multiscale analysis methods for models operating across multiple spatial or temporal domains
– Uncertainty quantification methods for multimodal data fusion and model discrepancy

Organisers: Cristobal Bertoglio, Bernoulli Institute for Maths/CS/AI, Groningen, NL; Jolanda Wentzel*, Cardiology, ErasmusMC, Rotterdam, NL (Email: j.wentzel@erasmusmc.nl).

Keywords: Digital Twin, Congenital Heart disease, Multiscale modeling, clinical decision making.

Relevant Conference Topics: Cardiovascular modelling, Multiscale modelling, Digital twins

Mini-symposium details:

Congenital heart disease (CHD) encompasses a broad spectrum of conditions, ranging from relatively simple malformations, such as coarctation of the aorta or valvular insufficiencies, to complex defects associated with a functionally univentricular circulation. These conditions can impose pressure or volume overload on the right ventricle, increasing myocardial stress and potentially leading to right ventricular dysfunction. This, in turn, is associated with adverse clinical outcomes, including heart failure and increased mortality. Despite advances in diagnosis and treatment, the substantial heterogeneity in cardiac anatomy and physiology across patients with CHD presents major challenges for clinical decision-making. These challenges are further compounded by growth-related changes in cardiac anatomy, function, and haemodynamics, from infancy to adulthood.

Digital twins are emerging as a promising approach to simulate patient-specific cardiac function and circulation, potentially supporting clinical decision-making throughout a patient’s lifetime. By integrating patient-specific anatomical, electrophysiological, and physiological data with computational modelling, digital twins could provide insights into the cardiac and haemodynamic consequences of different treatment strategies. This would enable clinicians to evaluate and compare potential medical and surgical interventions for individual patients, thereby supporting personalised treatment planning.

This mini-symposium focusses on the development of digital twins to characterise and understand cardiac function and haemodynamics across a broad spectrum of congenital heart conditions. Topics will include patient-specific multiscale modelling, integrating detailed three-dimensional models with lumped-parameter representations of the cardiovascular circulation, as well as in vitro and in vivo approaches for patient-specific parameter estimation and sensitivity analysis of these lumped-parameter models. Particular attention will be given to the verification and validation of these models against patient-specific measurements to establish their reliability and clinical relevance. Another key topic will be virtual surgery, in which patient-specific models are used to simulate and compare alternative surgical strategies and assess their potential haemodynamic consequences before intervention, thereby supporting personalised treatment planning.

Together, these approaches aim to advance patient-specific digital twins from computational models towards clinically relevant tools for understanding disease mechanisms and supporting personalized treatment planning.

Organisers: Felipe Galarce, Pontificia Universidad Católica de Valparaiso; Federica Caforio, University of Graz; Christian Vergara, Politecnico di Milano; Alfonso Caiazzo, WIAS Berlin; Cristóbal Bertoglio*, Netherlands (Email: c.a.bertoglio@rug.nl).

Keywords: Data assimilation, Cardiovascular Biomechanics, Optimization, Uncertainty Quantification.

Relevant Conference Topics: Cardiovascular modelling, Digital twins, Uncertainty quantification, Imaging and image processing

Mini-symposium details:

## BACKGROUND

Mathematical and computational models of the cardiovascular system have become increasingly sophisticated, enabling the description of blood flow, arterial mechanics, cardiac mechanics, and electrophysiology across multiple spatial and temporal scales. Despite these advances, a fundamental challenge remains in translating such models into reliable, patient-specific tools for clinical applications: how can unknown physiological quantities, model parameters, boundary conditions, tissue properties, and states be inferred from heterogeneous, incomplete, and uncertain data? Addressing this question requires the development of rigorous mathematical frameworks and efficient computational methods that account for the complexity of cardiovascular physiology and the limitations of available measurements.

This minisymposium is closely connected to the research vision of Alessandro Veneziani, whose seminal contributions emphasized mathematical rigor as a foundation for advancing cardiovascular modeling and bridging the gap between mathematical theory, computational simulation, and clinical applications.

## SCOPE AND PURPOSE

The minisymposium aims to bring together researchers working on inverse problems and data assimilation in cardiovascular modeling, fostering interactions between mathematical analysis, numerical methods, computational science, imaging, and experimental and clinical research. Its scope encompasses cardiovascular subsystems across a broad range of spatial and temporal scales, from cellular mechanisms to patient-level phenomena, and from individual cardiac cycles to short- and long-term physiological adaptation and remodeling.

Contributions may address human subjects, animal models, or mechanical phantoms, and may draw on experimental, in vivo, or in vitro measurements. Particular emphasis will be placed on approaches that improve the reliability, efficiency, robustness, and interpretability of inverse cardiovascular problems. By connecting researchers with complementary expertise, the minisymposium seeks to encourage methodological advances and interdisciplinary collaborations that support the development of more accurate and clinically relevant patient-specific models, continuing a research direction to which Alessandro Veneziani made seminal contributions.

## TOPICS COVERED

Topics of interest include, but are not limited to:

– Inverse problems in blood flow and hemodynamic modeling, arterial and cardiac mechanics, and cardiac electrophysiology.
– Identifiability, well-posedness, and mathematical analysis of inverse problems in cardiovascular systems.
– Parameter estimation, state estimation, uncertainty quantification, and sensitivity analysis.
– Robust and efficient optimization, regularization, and uncertainty-aware inference strategies.
– Variational data assimilation and sequential methods, including adjoint-based approaches, Kalman-type methods, and other techniques for estimating model parameters and physiological states.
– Integration of heterogeneous data sources, including magnetic resonance imaging, ultrasound imaging, electrophysiological recordings, catheterization measurements, and other in vivo and in vitro observations.
– Inverse modeling across multiple spatial and temporal scales, including cellular processes, organ-level function, patient-specific hemodynamics, and cardiovascular remodeling.
– Reduced-order models, surrogate models, and machine-learning-based approaches to accelerate repeated forward simulations and enable efficient inference in three-dimensional, multiphysics, and multiparameter systems.
– Validation, uncertainty-aware interpretation, and translation of inverse modeling methodologies toward experimental and clinical applications.

Overall, the minisymposium will highlight recent advances in the mathematical and computational foundations of inverse cardiovascular modeling, with the goal of promoting reliable, efficient, and interpretable approaches to parameter estimation and data assimilation in increasingly complex cardiovascular systems.

Organisers: Richard Schussnig, Oden Institute, U of Texas Austin; Damiano Lombardi, INRIA Paris; Pasquale Claudio Africa, SISSA, Italy; Alfonso Caiazzo*, WIAS Berlin, Germany (Email: caiazzo@wias-berlin.de).

Keywords: Surrogate modeling, Shape variability, Cardiovascular models, Inverse problems.

Relevant Conference Topics: Cardiovascular modelling, Artificial intelligence (AI) and machine learning, Data-driven modelling for biomedical applications, Numerical methods

Mini-symposium details:

Computational fluid dynamics of blood flow is increasingly used in forward and inverse modeling of the cardiovascular system, e.g., to compute hemodynamic quantities of interest or to address data assimilation problems using medical imaging. Despite recent developments in numerical methods, computing hardware, and data-driven methods, full three-dimensional patient-specific simulations still entail substantial computational costs and often represent a bottleneck for translation to clinical and preclinical applications. This minisymposium focuses on applications of reduced-order and data-driven surrogates for blood-flow simulations. Relevant topics include, but are not limited to, applications of surrogate modeling to forward inference, inverse problems, and uncertainty quantification, as well as the use of data-driven techniques to handle inter-patient variability.

The goal of the meeting is to bring together researchers working in numerical analysis and scientific computing, the mathematical and statistical aspects of machine learning, cardiovascular and hemodynamic modeling, medical imaging, and the formulation and solution of forward and inverse problems, fostering discussion across these themes. We welcome contributions focusing on mathematical and practical aspects, from both clinical and numerical perspectives. We encourage contributions that promote comparability of different reduction strategies through common settings and shared benchmarks, as well as contributions supporting open-source tools and reproducible research.

Organisers: Beata Ondrusova*, Institute of Mathematical Methods in Medicine and Data Based Modeling, Johannes Kepler University, Austria (Email: beata.ondrusova@jku.at); Argyrios Petras, Mathematical Methods in Medicine and Life Sciences, Johann Radon Institute for Computational and Applied Mathematics of the Austrian Academy of Sciences, Austria; Davide Baroli, Mathematical Methods in Medicine and Life Sciences, Johann Radon Institute for Computational and Applied Mathematics of the Austrian Academy of Sciences, Austria; Luca Gerardo-Giorda, Institute of Mathematical Methods in Medicine and Data Based Modeling, Johannes Kepler University, Austria.

Keywords: Digital twins, Patient-specific blood flow modelling, Computational haemodynamics, Circulatory support.

Relevant Conference Topics: Cardiovascular modelling, Digital twins, In-silico modelling and regulatory science, Medical devices and implants

Mini-symposium details:

BACKGROUND:
Over the past five years, more than 130,000 patients have relied on extracorporeal membrane oxygenation (ECMO) for circulatory or respiratory support in severe heart or lung failure [1]. Many more depend on ventricular assisting devices, percutaneous pumps, stents, heart valves and grafts. These technologies save lives, but their outcome depends on how they interact with each patient’s blood flow. Unfavorable flow can damage blood cells (hemolysis), trigger clots or bleeding, leave organs under-perfused, or cause a treated vessel to narrow again [2].

Computational models of blood flow, from fast lumped-parameter circuits [3] to detailed three-dimensional fluid dynamics, can reveal these effects before and during treatment [4, 5]. A digital twin is a patient-specific virtual replica that is personalized using imaging data and clinical measurements. Such twins could help clinicians choose cannula positions, pump speeds or stent designs suitable for a given patient [6]. Moreover, they could help engineers identify safer device designs, so that only the most promising candidates proceed to full laboratory and clinical testing.

SCOPE AND PURPOSE:
This mini-symposium brings together researchers working on computational modeling of blood flow in circulatory support systems and cardiovascular interventions, with the aim of developing reliable, patient-specific digital twins. These digital twins combine computational models with patient-specific anatomical, physiological, and clinical data to simulate cardiovascular hemodynamics, predict interactions between patients and medical devices, and support treatment planning and clinical decision-making. Contributions on a range of modeling approaches are welcome, including computational fluid dynamics (CFD), reduced-order models, fluid-structure interaction, multiscale simulations, and data-driven or hybrid methods.

Applications may include mechanical circulatory support, such as ECMO and ventricular assist devices, as well as interventions for congenital and acquired cardiovascular diseases. Studies examining the effects of patient anatomy, pathological conditions, device placement, and treatment strategies on blood flow are particularly welcome. Research on the design, optimization, and performance of devices such as pumps, oxygenators, cannulas, stents, heart valves, and vascular grafts is also encouraged, especially when it contributes to the development, calibration, or validation of patient-specific models and digital twins.

TOPICS COVERED:
Contributions are welcome on, but not limited to:
– Patient-specific modelling of ECMO, including cannula placement, recirculation, mixing zones and differential hypoxaemia
– Patient-specific modeling of cardiovascular interventions for congenital and acquired diseases
– Personalization of digital twins from medical imaging and bedside monitoring, including parameter estimation
– Flow in blood pumps, ventricular assist devices, percutaneous pumps and oxygenators, and their coupling with the native circulation
– Prediction of blood damage, platelet activation, thrombosis and bleeding in patients with circulatory support and interventional devices
– Surrogate models and machine learning for real-time blood flow simulation
– Verification, validation and uncertainty quantification of digital twins against in-vitro and clinical data
– In-silico trials and clinical translation of digital twins to support treatment planning and decision-making

REFERENCES:[1] Extracorporeal Life Support Organization (ELSO). Registry Dashboard | ECMO | Extracorporeal Membrane Oxygenation. Available at: https://www.elso.org/registry/elsoliveregistrydashboard.aspx[2] Padovani, D., Afsharimani, N., Cioncolini, A., et al. “Hematologic complications and design challenges in cardiovascular devices.” Communications Engineering, vol. 5, p. 167, 2026. https://doi.org/10.1038/s44172-026-00771-9[3] Roy, D., Mazumder, O., Sinha, A. and Khandelwal, S. “Multimodal cardiovascular model for hemodynamic analysis: Simulation study on mitral valve disorders.” PLOS ONE, vol. 16, no. 3, p. e0247921, 2021. https://doi.org/10.1371/journal.pone.0247921[4] Wickramarachchi, A., Gregory, S. D., Burrell, A. J. C. and Khamooshi, M. “Flow characterization of Maquet and Bio-Medicus multi-stage drainage cannulae during venoarterial extracorporeal membrane oxygenation.” Computers in Biology and Medicine, 2024. https://doi.org/10.1016/j.compbiomed.2024.108135[5] Hörwing, H., Parker, L., Svensson-Marcial, A., et al. “Hemodynamics in femoro-femoral venovenous extracorporeal membrane oxygenation using large eddy simulations.” Scientific Reports, vol. 15, p. 35229, 2025. https://doi.org/10.1038/s41598-025-22403-6[6] Wu, R., Ferreira, G., Khan, N. S., Mahmud, S. T., Stoop, J., Sohn, L. L., Leopold, J. A. and Randles, A. “Digital twins and digital models of the human circulatory system.” Nature Reviews Bioengineering, 2026. https://doi.org/10.1038/s44222-026-00427-5

Organisers: Gabor Zavodszky, University of Amsterdam, Netherlands; Keefe Manning, The Pennsylvania State University, Department of Biomedical Engineering, PA, USA; Noelia Grande Gutiérrez, Carnegie Mellon University, Department of Mechanical Engineering, PA, USA; Franck Nicoud*, University of Montpellier, IMAG CNRS, France (Email: franck.nicoud@umontpellier.fr).

Keywords: Thrombosis modeling, Blood elements and coagulation, micro and macroscale fluid mechanics, thrombus dynamics.

Relevant Conference Topics: Cardiovascular modelling, Multiscale modelling, Multiphysics modelling, Biofluid and biosolid mechanics

Mini-symposium details:

BACKGROUND
Thrombotic events remain a leading cause of morbidity and mortality worldwide, and their prediction is a major challenge for cardiovascular device design and patient-specific risk assessment. Despite progress in computational and experimental thrombosis modeling, predictive models usable in practical engineering and clinical computations are still lacking, largely because thrombosis couples biochemical kinetics to blood flow in a complex, multiscale manner.

SCOPE AND PURPOSE
This mini-symposium brings together researchers investigating thrombosis across spatial and temporal scales, using complementary computational, experimental, and theoretical approaches. Both microscopic studies (platelet transport and adhesion, coagulation kinetics, vWF unfolding, …) and macroscopic studies (continuum thrombus models, patient-specific and device-scale computations, …) are welcome, as are hybrid multiscale approaches bridging the two. All thrombosis types (arterial, venous, and material- or device-induced) are equally welcome.
Contributions on closely related topics that strongly impact thrombotic processes are also encouraged. Blood rheology controls the local stresses and residence times driving thrombus initiation and growth, while hemolysis under strong shear is both a safety criterion for blood-wetted devices and a coagulation activator via procoagulant factor release. By connecting these areas, the mini-symposium aims to foster interdisciplinary discussion and advance predictive thrombosis modeling.

TOPICS COVERED
– Microscopic scale: platelet transport, adhesion, aggregation; vWF unfolding under high shear; cell-resolved and particle-based simulations
– Macroscopic scale: continuum thrombosis models; patient-specific CFD; risk indices; reduced-order models
– Related topics: blood rheology; hemolysis and mechanical blood damage; complement system
– Multiscale and data-driven approaches: multiscale frameworks, uncertainty quantification, machine learning, digital twins, experimental and clinical validation
– Thrombus dynamics: initiation, growth, stability, and embolization

Organisers: Richard Lopata, Eindhoven University of Technology department of Biomedical Engineering; Frans van de Vosse*, Eindhoven University of Technology department of Biomedical Engineering (Email: f.n.v.d.vosse@tue.nl); Wouter Huberts, Eindhoven University of Technology department of Biomedical Engineering.

Keywords: cardiovascular modeling, decision support, in-silico trials, digital twins.

Relevant Conference Topics: Cardiovascular modelling, Artificial intelligence (AI) and machine learning, Digital twins, Uncertainty quantification

Mini-symposium details:

BACKGROUND
Computational modeling is increasingly transforming healthcare by enabling the development of representations of patient-specific physiological systems, often referred to as digital twins. In cardiovascular medicine, digital twin technology has emerged as a promising framework for supporting patient-specific diagnosis, risk stratification, treatment planning, and the evaluation of novel therapies and devices. These developments are driven by advances in mechanistic modeling, data-driven approaches, medical imaging, and the growing availability of clinical data. At the same time, artificial intelligence (AI), including emerging generative AI methods, is creating new opportunities to accelerate model development, improve computational efficiency, and facilitate the translation of modeling technologies into clinical practice.
Despite these advances, several scientific and practical challenges remain. These include the integration of mechanistic and data-driven modeling approaches, model validation and uncertainty quantification, credibility of computational modeling and simulation for clinical applications, and ensuring the quality and reliability of the data used for model development and deployment. Addressing these challenges is essential for realizing the full potential of digital twins as tools for clinical decision support and in-silico clinical trials.
SCOPE AND PURPOSE
This mini-symposium will explore recent developments in digital twin technology for cardiovascular applications, with a particular focus on model-predictive clinical decision support and in-silico clinical trials. The symposium aims to bring together researchers working on computational biomechanics, cardiovascular physiology, data science, artificial intelligence, and clinical translation.
Contributions will address mechanistic models, data-driven models, and hybrid approaches. Applications across a broad range of cardiovascular diseases and patient populations are welcomed, with examples including coronary artery disease, cerebral artery disease, aortic aneurysms and stenosis, heat valve disorders, and fetal cardiovascular disfunction. The symposium will also highlight how AI and generative AI can contribute to reduced-order modeling, surrogate model development, synthetic patient generation, data augmentation, sensitivity analysis, and uncertainty quantification. Furthermore, the importance of data quality, data certification, and model credibility for regulatory and clinical acceptance will be discussed.
The overall objective is to provide a multidisciplinary perspective on the opportunities and challenges associated with the next generation of cardiovascular digital twins and their translation into healthcare practice.
TOPICS COVERED
– Cardiovascular digital twins and patient-specific modeling
– Model-predictive clinical decision support systems
– In-silico clinical trials and virtual patient cohorts
– Mechanistic models of cardiovascular physiology and biomechanics
– Data-driven and machine-learning approaches in cardiovascular medicine
– Hybrid modeling strategies integrating physics-based and AI-based methods
– Reduced-order and surrogate modeling techniques
– Generative AI for model development and synthetic patient generation
– Data augmentation methodologies
– Sensitivity analysis and uncertainty quantification
– Model validation, verification, and credibility assessment
– Data quality assurance, certification, and regulatory considerations
– Translation of computational modeling technologies into clinical practice

Organisers: Aike Qiao*, Beijing University of Technology, China (Email: qak@bjut.edu.cn).

Keywords: Computational modeling, Cardiovascular implants/intervention devices, Structure design and mechanical analysis, Surgical planning.

Relevant Conference Topics: Cardiovascular modelling, Multiscale modelling, Medical devices and implants

Mini-symposium details:

1 BACKGROUND
Cardiovascular implants/intervention devices, such as stents, grafts, coils, flow diverters, prosthetic heart valves, etc., have transformed patient outcomes, yet challenges persist in biocompatibility, durability, and personalized design. Currently, a series of techniques have been used for implant design, performance evaluation and fabrication, which include computational modeling and simulation, machine learning, additive manufacturing as well as in vitro and in vivo experimentation. However, further improvement in clinical outcomes still requires detailed evaluation of the biomechanical performance of the devices. Computational modelling offers a highly efficient approach for understanding and analyzing the key parameters that influence the success of devices, including finite element analysis (FEA), computational fluid dynamics (CFD) simulation, patient-specific modeling and machine leaning. For decades, computational modeling and simulation have been successfully used to support the design, development and evaluation of a wide range of medical devices. AI-driven approaches now offer unprecedented opportunities to optimize the performance of implants/intervention devices, predict long-term outcomes, and accelerate FDA-compliant development. The aim of this mini-symposium is to bring together specialists in biomedical engineering, biomechanics, biomaterials science, tissue engineering and various aspects of processing and manufacturing as well as medical practitioners to discuss recent advances in cardiovascular implants/intervention devices, focusing on the insights gained from computational modeling and simulation.

2 MAIN FEATURES OF THE MINI-SYMPOSIUM
– Considering the state-of-the-art studies of cardiovascular implants via cross-disciplinary, multiscale and artificial intelligence/machine learning approaches.
– Gaining insights into the clinical issues associated with cardiovascular implants and intervention processes.
– Focusing on the design, bio-fabrication and in silico evaluation of cardiovascular implants, including but not limited to additive manufacturing.
– Cross-disciplinary synergy: Computational biomechanics, AI, materials science, and clinical practice.
– Multiscale & AI-driven modeling: From molecular interactions to systemic hemodynamics.
Clinical translation: Addressing thrombosis, tissue remodeling, and post-op complications via virtual trials.

3 SCOPE OF THE MINI-SYMPOSIUM
The topics of the mini-symposium include, but not limited to, the following:
– Modeling the biomechanical performance of cardiovascular implants, including stents, prosthetic heart valves, etc.
– Design, optimization, additive manufacturing and evaluation of novel cardiovascular implants, including personalized devices.
– Computational algorisms based on medical imaging and machine learning for the modelling of fluid dynamics and fluid-solid interaction after deployment of cardiovascular implants.

4 POTENTIAL SPEAKERS
Organizers of the mini-symposium will consider the following recommendations when selecting speakers in the mini-symposium:
– Speakers from international research groups are encouraged to present their work.
– Speakers who can provide an overview of the topic area, and bring new ideas for continued research and application are also welcomed.

5 PROGRAM PROPOSAL
– At least 9 regular talks will be presented, and each talk may be for 15 min.
– One ‘session keynote’ will be organized, and the keynote will be for 25 min.
– At the end of symposium, 30 minutes of round-table discussion will be arranged which is open for all participants.

Organisers: Dean Chou, Department of Biomedical Engineering, National Cheng Kung University, Taiwan; shufan yang*, United Kingdom (Email: s.f.yang@leeds.ac.uk); Satoshi Ii, Department of Mechanical Engineering, Institute of Science Tokyo, Japan.

Keywords: Patient-Specific Digital Twins, Fluid-Structure Interaction, Artificial Intelligence, Physics-Informed Neural Networks.

Relevant Conference Topics: Data-driven modelling for biomedical applications, Biological heat and mass transfer, Biofluid and biosolid mechanics, High-performance computing

Mini-symposium details:

BACKGROUND
Patient-specific digital twins, virtual replicas calibrated to and updated with each patient’s clinical data, promise personalised planning of medical interventions. Yet most current twins assume rigid tissue or lumped circulation models, because fluid-structure interaction (FSI) simulation is slow, needs wall properties that routine imaging cannot measure, and is numerically fragile. This gap matters most where tissue deformation is the clinical question: aneurysm rupture, aortic dissection, valve and stent-graft performance, and airway or joint loading. Artificial intelligence (AI) and machine learning (ML) are now bringing FSI-based twins within reach. Learned surrogates predict coupled flow and wall mechanics in seconds rather than hours, and data assimilation can infer tissue properties from 4D flow MRI and cine CT.
SCOPE AND PURPOSE
Topics include, but are not limited to:
– image-to-FSI pipelines, including recovery of the stress-free geometry
– inverse estimation of patient-specific wall stiffness, prestress and boundary conditions
– physics-informed, neural-operator and reduced-order surrogates for coupled problems
– robust coupling for large deformation, contact and the added-mass regime
– uncertainty quantification and longitudinal twins that track disease and treatment
– cardiovascular, neurovascular, respiratory and musculoskeletal applications
Purpose
This Minisymposium aims to move patient-specific FSI digital twins from research prototypes to bedside decision support. It brings together computational mechanicians, data scientists, biomedical engineers and clinicians. Contributions are particularly welcome that are validated against in vivo or clinical data, address verification, validation and regulatory requirements, or are developed with industry partners. The session will showcase state-of-the-art results, identify open challenges and build international collaborations that link methodological advances directly to clinical need.

Organisers: Alberto Marzo*, School of Mechanical, Aerospace and Civil Engineering, University of Sheffield, Sheffield, UK (Email: a.marzo@sheffield.ac.uk).

Keywords: In silico medicine, Clinical translation, Human digital twins, Verification, Validation and Uncertainty Quantification (VVUQ).

Relevant Conference Topics: Computational medicine, Digital twins, Uncertainty quantification, Medical devices and implants

Mini-symposium details:

IN SILICO MEDICINE IN PRACTICE: DEMONSTRATING PATHWAYS TO CLINICAL ADOPTION AND HEALTHCARE IMPACT

Alberto Marzo1,2
1 INSIGNEO Institute for in silico medicine, University of Sheffield, Sheffield, UK, a.marzo@sheffield.ac.uk
2 School of Mechanical, Aerospace and Civil Engineering, University of Sheffield, Sheffield, UK, a.marzo@sheffield.ac.uk

BACKGROUND
In silico medicine represents the not-so-far future and perhaps our best hope to make a significant, transformative impact in healthcare. Computer models to simulate the functioning of the human body are viewed increasingly as one of the most promising tools to embrace and better understand the complexity of human pathophysiology, ranging from detailed multi-physics descriptions to human digital twins that allow personalised guidance for diagnosis, treatment, and clinical management. However, the journey to clinical translation and adoption in healthcare is not trivial. Computational applications must ‘tick many boxes’ to complete this journey, including rigorous verification, validation, and uncertainty quantification (VVUQ), medical device software certification, regulatory navigation, and alignment with clinical workflows. Even when these technical requirements are met, making the ‘jump’ to adoption in healthcare presents its own distinct operational and cultural challenges. While the scientific literature offers a rich range of basic research focusing on detailed numerical and experimental methods, the impact of such cross-disciplinary effort is now starting to emerge, demonstrating how advanced modelling approaches can cross the threshold into routine medical practice.

SCOPE AND PURPOSE
The primary objective of this mini-symposium is to showcase modelling approaches that have successfully travelled along the pathway to clinical adoption, or are progressing at pace with strong translational foundations. By bringing together concrete success stories and mature translational pipelines, the session aims to shine a light on the essential ingredients required to repeat this journey and maximize real-world healthcare impact.
This mini-symposium aims to provide an open, interdisciplinary forum bringing together computational modellers, biomedical engineers, clinicians, regulatory experts, and industry partners. Discussions will focus on how state-of-the-art methodologies can be aligned directly towards specific, unsolved clinical challenges and hypotheses. Key emphasis will be placed on the importance of early clinical and industrial engagement, co-design, clinical trial integration, and overcoming the practical hurdles of healthcare deployment.

TOPICS COVERED
– Patient-specific, image-based computational modelling applied to unsolved clinical challenges
– Human digital twins and in silico clinical trials for personalized diagnosis and therapy
– Verification, validation, and uncertainty quantification (VVUQ) frameworks ensuring model credibility in a clinical context
– Reduced-order and surrogate modelling for real-time clinical decision support
– Medical device software certification, regulatory navigation, and translation pathways
– Strategies for early clinical engagement, co-design, and integration into hospital workflows
– Exemplar translational case studies demonstrating real-world clinical impact across physiological systems

Organisers: Gianluigi Rozza, SISSA, mathLab, Trieste (Italy); Pasquale Claudio Africa*, SISSA, mathLab, Trieste (Italy) (Email: pafrica@sissa.it); Pierfrancesco Siena, SISSA, mathLab, Trieste (Italy).

Keywords: cardiovascular simulation, numerical methods, reduced order modeling, data-driven modeling.

Relevant Conference Topics: Cardiovascular modelling, Data-driven modelling for biomedical applications, Numerical methods, High-performance computing

Mini-symposium details:

BACKGROUND
Computational modeling is increasingly used to support diagnosis, treatment planning, and medical device design in cardiovascular medicine. However, realistic simulations of blood flow, vessel wall mechanics, and cardiac electromechanics remain computationally demanding. Multiscale and nonlinear coupling, complex patient-specific geometries, and the need for uncertainty quantification, parameter calibration, and near real-time predictions call for efficient, reliable, and scalable computational strategies. Addressing them is essential to enable routine use of simulations in clinical and industrial workflows.

SCOPE AND PURPOSE
This minisymposium welcomes contributions from both physics-based and data-driven approaches, with equal consideration for each. On the physics-based side, topics include advanced numerical methods and discretization techniques, scalable solvers and preconditioners for coupled multiphysics problems, projection-based reduced order models, and hyper-reduction. On the data-driven side, we invite work on neural surrogates, physics-informed neural networks, operator learning, and non-intrusive reduced order models. Topics of interest also include multi-fidelity strategies, data assimilation, inverse problems, and uncertainty quantification for patient-specific modeling. Contributions on high-performance computing are equally encouraged, including parallel algorithms, GPU acceleration, scalable mesh generation and partitioning, and performance portability on modern supercomputers.

Beyond presenting new methods, the session aims to foster an open discussion on the strengths and limitations of each family of approaches in terms of accuracy, computational cost, generalization, robustness, and interpretability, and on the settings in which each is most appropriate. Contributions featuring benchmark problems, validation against in vitro or in vivo data, open-source software, and clinically oriented applications are particularly welcome.

The minisymposium is intended to bring together numerical analysts, computational scientists, data scientists, bioengineers, and clinicians, and to promote exchange across communities working on cardiovascular simulation.

Organisers: Philippe Bijlenga, Neurosurgery, Geneva University Hospitals, Geneva, Switzerland; Anne M. Robertson, Department of Mechanical Engineering and Materials Science, University of Pittsburgh, Pittsburgh, PA USA; Yasutaka Tobe, Department of Mechanical Engineering and Materials Science, University of Pittsburgh, Pittsburgh, PA USA; Juan R. Cebral, Bioengineering Department, George Mason University, Fairfax, Virginia, USA; Norman Juchler*, Institute of Computational Life Sciences, Zurich University of Applied Sciences, Waedenswil, Switzerland (Email: norman.juchler@zhaw.ch); Sandrine Morel, HUG-NeuroCentre, Geneva University Hospitals, Geneva, Switzerland; Sven Hirsch, Institute of Computational Life Sciences, Zurich University of Applied Sciences, Waedenswil, Switzerland.

Keywords: intracranial aneurysm, biomechanical modeling, medical image analysis, multimodal data analysis.

Relevant Conference Topics: Cardiovascular modelling, Constitutive modelling – soft and hard tissues, Biology and its links to diseases, Imaging and image processing

Mini-symposium details:

1. BACKGROUND
Intracranial aneurysms develop and evolve through complex interactions between genetic, biological, hemodynamic, biomechanical, and environmental factors. Despite substantial advances in medical imaging, computational modeling, and clinical risk prediction, the mechanisms governing aneurysm formation, growth, and rupture remain incompletely understood. Consequently, reliable patient-specific risk assessment remains a major challenge.

Current clinical decision-making relies predominantly on population-based risk estimates, which may not adequately capture individual disease characteristics. Meanwhile, the increasing availability of multimodal clinical, imaging, and biological data, together with advances in computational and statistical methods, creates new opportunities to investigate aneurysm behavior and develop more personalized predictive models.

2. SCOPE AND PURPOSE
This mini-symposium aims to bring together interdisciplinary research addressing the multifactorial nature of intracranial aneurysms, with particular emphasis on integrating complementary data sources and modeling approaches.

The symposium will highlight recent advances in understanding the physiological, hemodynamic, biomechanical, and biological mechanisms underlying aneurysm development and progression. It will further explore how mechanistic modeling, advanced image analysis, and data-driven methods can be combined to improve disease characterization and individualized risk prediction.

Contributions spanning clinical research, vascular biology, medical imaging, computational biomechanics, and data science are encouraged. Particular interest lies in approaches that move beyond isolated risk factors toward integrated, patient-specific models of aneurysm behavior.

3. TOPICS COVERED
Topics of interest include, but are not limited to:
– Hemodynamics and biomechanics: Investigation of blood flow, vascular wall mechanics, and their interactions with aneurysm development and progression.
– Mechanistic and patient-specific modeling: Computational simulations, multiscale modeling, and digital twins incorporating individual anatomy and physiological conditions.
– Multimodal imaging and image analysis: Advanced vascular imaging, quantitative morphology, radiomics, vessel wall imaging, and emerging imaging technologies.
– Biological and molecular characterization: Integration of genetic, molecular, microbiomic, and histopathological markers with clinical and computational data.
– Multifactorial risk prediction: Statistical inference, machine learning, uncertainty quantification, and harmonization of heterogeneous multicenter datasets for personalized risk assessment.

The mini-symposium seeks to foster interdisciplinary exchange and identify opportunities for translating multimodal and mechanistic insights into improved clinical decision-making.

Organisers: Tu-Ky Ly, Informatics Institute, University of Amsterdam, Netherlands; Benine Brouwer, Informatics Institute, University of Amsterdam, Netherlands; Antonio Acquaviva, Department of Physiology, Amsterdam Cardiovascular Sciences, Atherosclerosis and Aortic disease, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands; Roland V Bumbuc, Department of Plastic, Reconstructive and Hand Surgery, Amsterdam Movement Sciences (AMS) Institute, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands; Vivek M Sheraton*, Informatics Institute, University of Amsterdam, Netherlands (Email: v.s.muniraj@uva.nl); Shivam Kumar, Informatics Institute, University of Amsterdam, Netherlands.

Keywords: Cell-based modelling, Local and systemic immune dynamics, Spatiotemporal modelling, Inflammatory responses.

Relevant Conference Topics: Multiscale modelling, Multiphysics modelling, Biology and its links to diseases, In-silico modelling and regulatory science

Mini-symposium details:

BACKGROUND
Immune responses emerge from complex interactions across biological scales, from molecular signals to organs. These interactions coordinate host defense, tissue repair, and homeostasis. However, persistent or dysregulated immune activity, can sustain inflammation, impair wound healing, and contribute to tumour progression.
A central challenge is to understand how local cell-cell and cell-microenvironment interactions give rise to tissue-scale behaviour and systemic immune dynamics. Mechanistic computational modelling provides a framework for formulating hypotheses about these cross-scale processes and testing their consequences alongside experimental and clinical data. Within this framework, cell-based approaches represent individual-cell states, behaviours, and interactions, while continuum approaches describe transport processes and tissue-scale fields. These approaches can be combined within multiscale frameworks to couple processes across levels of biological organisation. Advances in quantitative imaging and omics provide increasingly rich data to inform model structure and support parameter inference, calibration, and validation. However, implementing these heterogeneous data into mechanistic models, capturing biological variability, and validating predictions across scales remains significant challenges.
SCOPE AND PURPOSE
This mini-symposium will bring together researchers developing and applying computational and mathematical models of immune and inflammatory dynamics, with emphasis on how cellular behaviours, tissue microenvironments, and systemic processes are represented. Applications will include immune-endothelial interactions, oncology, wound healing and tissue repair, vascular barrier function, and host-pathogen interactions. The aim is to share modelling approaches, explore how experimental and/or omics data can support model development, and identify shared challenges across these different application areas. Contributions may span mechanistic studies of immune regulation and translational applications related to disease progression and treatment response. Particular emphasis will be placed on model calibration, parameter inference, uncertainty quantification, and computational tractability. By bringing together computational, experimental, and biomedical perspectives, the mini-symposium will examine how models can generate testable hypotheses, provide mechanistic interpretations of observed immune behaviou and inform experimental design.
TOPICS COVERED
The mini-symposium invites contributions on the following topics:
Cell-based and agent-based modelling of immune cell migration, activation, recruitment, and interactions
Spatiotemporal and multiscale modelling of inflammatory responses, including communication between local tissue processes and systemic immune dynamics
Computational models of tumour-immune interactions, the tumour microenvironment, and responses to immunotherapy
Modelling inflammation, immune regulation, and tissue repair during wound healing
Immune-endothelial interactions, endothelial barrier function, and immune cell passage across endothelial monolayers
Host-pathogen interactions, including immune-mediated pathogen clearance, persistence, and tissue damage
Integration of transcriptomic, proteomic, and other omics data into mechanistic models of immune responses
Model calibration, sensitivity analysis, uncertainty quantification, and validation using experimental or clinical observations

Organisers: Makoto Ohta, Institute of Fluid Sciences, Tohoku University, Sendai, Japan; Hitomi Anzai, Institute of Fluid Sciences, Tohoku University, Sendai, Japan; Ryo Torii, Department of Mechanical Engineering, University College London, London, UK; Sven Hirsch*, Institute of Computational Life Sciences, Zurich University of Applied Sciences, Waedenswil, Switzerland (Email: sven.hirsch@zhaw.ch); Norman Juchler*, Institute of Computational Life Sciences, Zurich University of Applied Sciences, Waedenswil, Switzerland (Email: norman.juchler@zhaw.ch).

Keywords: cardiovascular system, anatomical variability, vascular morphology, data-driven modeling.

Relevant Conference Topics: Cardiovascular modelling, Artificial intelligence (AI) and machine learning, Imaging and image processing

Mini-symposium details:

1. BACKGROUND
The human vascular system exhibits substantial anatomical variability, shaped by developmental, genetic, physiological, and environmental factors. Variations in vascular geometry and topology influence local blood flow and mechanical conditions and may contribute to the development and progression of vascular diseases, including aneurysms, stenoses, and vascular malformations. Understanding this variability across individuals and populations is therefore essential for investigating vascular function, disease mechanisms, and patient-specific risks.

Advances in medical imaging and computational methods provide increasingly detailed representations of vascular anatomy. At the same time, the growing availability of large-scale imaging datasets and artificial intelligence (AI) techniques creates new opportunities to systematically quantify, analyze, and model anatomical variability. However, challenges remain in data standardization, morphological characterization, model generalizability, and the integration of data-driven approaches with physical and physiological knowledge.

2. SCOPE AND PURPOSE
This mini-symposium aims to bring together interdisciplinary research on data-driven and AI-based methods for characterizing and modeling anatomical variability in vascular systems.

Particular emphasis will be placed on quantitative representations of vascular geometry and topology, statistical and machine learning approaches for analyzing population-level variability, and the integration of data-driven models with computational simulations. The symposium will also explore methodological challenges related to heterogeneous imaging datasets, uncertainty quantification, and the reproducibility and interpretability of AI-based approaches.

Contributions from medical imaging, computational biomechanics, applied mathematics, data science, and clinical research are encouraged, with applications spanning healthy vascular anatomy and vascular disease.

3. TOPICS COVERED
Topics of interest include, but are not limited to:
– Vascular imaging and data processing: Segmentation, reconstruction, annotation, standardization, and harmonization of large-scale vascular imaging datasets.
– Quantitative morphology and anatomical variability: Geometric and topological descriptors, radiomics, statistical shape analysis, and population-based vascular characterization.
– AI and data-driven modeling: Machine learning, generative models, and statistical approaches for representing, analyzing, and predicting vascular anatomy.
– Integration with computational modeling: Combining data-driven approaches with hemodynamic and biomechanical simulations to investigate vascular structure-function relationships.
– Uncertainty, reproducibility, and generalizability: Quantification of anatomical variability and modeling uncertainty, validation across populations, and reliable, interpretable AI methodologies.

Organisers: Janaki Raman Rangarajan, VPH – The Society for In Silico Medicine, Belgium; Yidan Xue*, Department of Computer Science, The University of Manchester, UK (Email: yidan.xue@manchester.ac.uk); Adesola Ademiloye, Department of Biomedical Engineering, Swansea University, Swansea, UK; Philippe Favre, Zimmer Biomet, Switzerland; Martha De Cunha Maluf-Burgman, Edwards Lifesciences, US.

Keywords: computational modelling and simulation (CM&S), model credibility, verification and validation, uncertainty quantification.

Relevant Conference Topics: Uncertainty quantification, Experimental validation, In-silico modelling and regulatory science, Medical devices and implants

Mini-symposium details:

BACKGROUND
The use of computational modelling and simulation (CM&S) is becoming increasingly integral to the medical device lifecycle, supporting activities from material selection, design and performance assessment to regulatory evaluation and post-market change management. In silico approaches can complement experimental and clinical evidence, explore device performance across a broader range of conditions, and support more efficient evidence generation. For material and device testing, CM&S has already been widely used to predict stress and strain distributions, fatigue and durability, wear, corrosion and degradation behaviour, and to identify worst-case designs, sizes and loading conditions for physical testing. Used credibly, such models can focus and reduce bench test matrices, extrapolate results beyond practically testable conditions, support the reduction, refinement and replacement of animal testing, and complement clinical investigations. However, their wider use in regulatory decision-making depends on confidence that models and the evidence they generate are credible for their intended purpose [1]. The ASME V&V 40-2018 standard provides a risk-informed framework for assessing model credibility in relation to the context of use and associated model risk [2], and regulatory guidance such as the U.S. FDA guidance on assessing the credibility of CM&S in medical device submissions has built on this approach [3]. Recent developments have further emphasised the importance of robust credibility evidence through verification, validation and uncertainty quantification (VVUQ) [4,5].

SCOPE AND PURPOSE
This mini-symposium aims to bring together researchers, industry, regulators, notified bodies, standards experts and other stakeholders to discuss advances and remaining challenges in developing and using credible in silico evidence for medical devices. It will consider both the technical foundations of model credibility assessment and the broader processes needed to translate computational evidence into regulatory and conformity-assessment practice. Focus will be given to how credibility requirements should be tailored to the intended use of a model, how existing validation evidence can be transferred or extended to new devices, materials and patient populations, how computational and physical material testing can be combined to strengthen the overall body of evidence, and how emerging modelling approaches can be evaluated within existing regulatory frameworks. The symposium aims to identify shared good practices, open research questions and priorities for future standards and guidance.

TOPICS COVERED
Contributions are invited on topics including:
– Verification, validation and uncertainty quantification: Methods for assessing the numerical accuracy, predictive capability and uncertainty of computational models. Contributions may include methodological advances, experimental or clinical validation studies, and applications of VVUQ to medical device evaluation.
– CM&S for material testing and characterisation: Use of computational models to support material and structural testing of medical devices, including constitutive modelling of metals, polymers, biological and bioresorbable materials, prediction of fatigue, durability, wear, corrosion and degradation, and worst-case selection for bench testing. Contributions may address calibration and validation of material models against experimental data, characterisation of material variability and uncertainty, and the use of in silico methods to complement, focus or partially replace physical tests.
– Risk-informed model credibility assessment and context of use: Approaches for establishing model credibility requirements based on the intended context of use and associated model risk. Contributions may address credibility assessment frameworks, risk-informed evidence planning and practical implementation in medical device applications.
– Model applicability, transferability and evidence reuse: Methods for assessing the applicability of existing validation evidence to new contexts of use, device designs or patient populations. Contributions may explore approaches for evaluating evidence transferability, identifying credibility gaps and determining additional evidence requirements.
– Virtual populations, in silico trials and digital twins: Development and application of virtual populations, patient-specific models and in silico clinical trials for medical device evaluation. Contributions may address population representativeness, model credibility, clinical relevance and the use of virtual evidence to support device safety and performance assessment.
– Data-driven, AI-enabled and hybrid mechanistic models: Development and evaluation of data-driven, AI-enabled and hybrid modelling approaches for medical device applications. Contributions may address model interpretability, generalisability, uncertainty, validation and the challenges of establishing credibility for emerging modelling techniques.
– Integration of in silico evidence with bench, animal, clinical and real-world evidence: Approaches for combining computational predictions with other sources of evidence to support medical device evaluation across the device lifecycle. Contributions may explore integrated evidence generation strategies, complementary validation methods and the role of in silico evidence in reducing, refining or replacing experimental and clinical evidence requirements.
– Reproducibility, documentation and reporting of in silico evidence: Good practices for model and data management, software quality, version control and transparent reporting of computational studies. Contributions may address reporting templates, model lifecycle management and change control, and how credibility evidence can be communicated effectively to regulators and notified bodies.
– Standards, regulatory pathways, conformity assessment and practical case studies of regulatory use: Developments in regulatory frameworks, standards and guidance relevant to the evaluation and acceptance of computational evidence. Contributions may include practical case studies, experiences of regulatory engagement and challenges in translating credible modelling approaches into regulatory and conformity-assessment practice.
The mini-symposium aims to encourage cross-disciplinary discussion on how computational models can progress from scientifically robust simulations to credible evidence that can be relied upon in medical device evaluation and decision-making.

REFERENCES[1] Craven BA, Basciano CA, Afshari P, et al. Computational modeling and simulation for medical devices: a summary of the 2024 FDA/MDIC Symposium. Progress in Biomedical Engineering. 2026;8:013001.[2] American Society of Mechanical Engineers. Assessing credibility of computational modeling through verification and validation: application to medical devices. ASME V&V 40-2018. New York (NY): American Society of Mechanical Engineers; 2018.[3] U.S. Food and Drug Administration. Assessing the credibility of computational modeling and simulation in medical device submissions: guidance for industry and Food and Drug Administration staff. Silver Spring (MD): FDA; 2023.[4] Horner M, Amar A, Frangi AF, Maluf-Burgman MDC, Marchal T, Pappalardo F. Ensuring the quality of in silico evidence: application to medical devices. Brief Bioinform. 2026;27(4):bbag442.[5] Xue Y, Sarrami Foroushani A, Kreuzer S, et al. Risk-informed framework for in silico regulatory evaluation of medical devices. Device. 2026;101303. doi: 10.1016/j.device.2026.101303.

Organisers: Yonghui Qiao*, School of Power and Energy, Northwestern Polytechnical University, China (Email: yhqiao@nwpu.edu.cn).

Keywords: Human-environment interaction, Multiphase Flow, Multiphysics modelling, Heat and Mass Transfer.

Relevant Conference Topics: Cardiovascular modelling, Multiscale modelling, Multiphysics modelling, Respiratory systems

Mini-symposium details:

BACKGROUND
Human-machine-environment systems are widely encountered in aviation, spaceflight, transportation, maritime, and underwater operations. Their operation involves complex flow and transport problems associated with multiphase phenomena, multiphysics and multiscale effects, and heat and mass transfer, which directly influence system operation, environmental control, human exposure, and physiological responses. Meanwhile, operating conditions such as acceleration and changes in gravity can alter body-fluid distribution and circulatory states, extending fluid-dynamics research from external engineering flows to internal physiological flows in the respiratory and cardiovascular systems. In recent years, advances in computational fluid dynamics, multiphysics and multiscale simulation, artificial intelligence, and high-performance computing have increasingly promoted integrated research across engineering flows, the environment external to the human body, and internal biofluid dynamics, while further expanding the capabilities of numerical analysis for complex flow problems in human-machine-environment systems.

SCOPE AND PURPOSE
This mini-symposium will focus on recent developments and applications of computational fluid dynamics methods in human-machine-environment systems. The scope covers complex flow and transport in engineering systems, interactions between humans and their environments, and internal biofluid dynamics. The research methods include, but are not limited to, multiphase flow, heat and mass transfer, multiphysics simulation, and multiscale simulation. Applications may involve typical human-machine-environment systems in aviation, spaceflight, transportation, maritime, and underwater operations.
The aim of this mini-symposium is to bring together researchers in fluid mechanics, applied mathematics, and computational science to discuss recent advances in numerical methods and their applications to flow problems in human-machine-environment systems, promote communication and learning across different research areas, and advance interdisciplinary research connecting engineering flows with human biofluid dynamics.

TOPICS COVERED
Complex Flow and Transport in Human-Machine-Environment Systems
Human-Environment Interaction
Human Biofluid Dynamics
Advanced Numerical Simulation Methods for Human-Machine-Environment Systems

Organisers: Martin Genet*, Solid Mechanics Laboratory, École Polytechnique, France (Email: martin.genet@polytechnique.edu); Daniel Hurtado, Pontificia Universidad Católica de Chile.

Keywords: Computational modeling, Data assimilation, Respiratory mechanics, Biomedical engineering.

Relevant Conference Topics: Multiscale modelling, Digital twins, Imaging and image processing, Respiratory systems

Mini-symposium details:

BACKGROUND
Computational modeling of the respiratory system continues to gain momentum in the biomedical engineering community. Indeed, modern modeling and simulation tools can help strengthen our understanding of lung physiology, especially structure-property-function relationships in health and disease, in an objective and quantitative manner. Moreover, as in many other application domains, digital twins are currently emerging in respiratory medicine as potential next-generation tools to support the diagnosis, prognosis and treatment of chronic diseases (e.g., chronic obstructive pulmonary disease or pulmonary fibrosis) and acute conditions (e.g., acute respiratory distress syndrome), paving the way toward computer-aided decision making. But specific scientific challenges lie on this path, related notably to the complex hierarchical structure of the lungs, from the alveoli to the whole organ; to the intricate coupling between their multiple constituents—tissue, air and blood—and with the surrounding organs; and to the limited and indirect nature of the available clinical data. These challenges are being addressed by a rather diverse community of engineers, mathematicians, physicists, physiologists and clinicians.

SCOPE AND PURPOSE
The objective of this mini-symposium is to gather and structure this community, provide an overview of the current state of the art in the field, and pinpoint the main theoretical and practical bottlenecks that still hinder the clinical translation of pulmonary digital twins. Open to researchers from academia and industry alike, it welcomes methodological and fundamental contributions as well as practical applications, and will also offer an opportunity to discuss the future directions of computational respiratory medicine.

TOPICS COVERED
The mini-symposium is dedicated to all aspects of computational and mathematical pulmonology, notably: mechanistic and data-driven models of lung mechanics and function in disease; multiscale frameworks upscaling microstructural features to the whole-organ response; airflow dynamics, including the effects of airway structure and remodeling; and gas exchange through the alveolar blood-air barrier, accounting for the impact of the alveolar microstructure on oxygen and carbon dioxide diffusion. Contributions on the structural and mechanical characterization of lung tissue, airways and pulmonary vasculature under physiological and pathological conditions are also welcome, as they are essential to inform such models. Finally, the scope extends to the use of artificial intelligence to accelerate model construction and numerical simulation, as well as to model validation and clinical applications, from the assessment of pulmonary function to patient-specific digital twins.

Organisers: Neeraj Kavan Chakshu*, Zinkiewicz Institue for Modelling, Data and AI, Faculty of Science and Engineering, Swansea University, UK (Email: n.k.chakshu@swansea.ac.uk); Ketan Rajawat, Dept. of Electrical Engineering, IIT Kanpur, India; Adesola Ademiloye, Department of Biomedical Engineering, Faculty of Science and Engineering, Swansea University, UK; Perumal Nithiarasu, Zinkiewicz Institue for Modelling, Data and AI, Faculty of Science and Engineering, Swansea University, UK.

Keywords: Digital Twins, Cardiovascular Modelling, Data-driven Modelling, AI.

Relevant Conference Topics: Cardiovascular modelling, Artificial intelligence (AI) and machine learning, Digital twins, Numerical methods

Mini-symposium details:

BACKGROUND
The next frontier in cardiovascular modelling lies not only in developing increasingly sophisticated computational simulations but also in transforming them into intelligent, adaptive, and clinically relevant digital twin systems. The convergence of computational biomechanics, artificial intelligence, advanced sensing technologies, and emerging agent-based AI frameworks is creating new opportunities for how cardiovascular conditions can be investigated, monitored, and managed. Beyond traditional patient-specific simulations, these developments offer the potential for digital twins that can assimilate new information, coordinate computational workflows, explore alternative scenarios, and support personalised clinical decision-making.

Building on the discussions initiated at the previous mini-symposium during CMBE 2026 in Kobe, Japan, this mini-symposium aims to explore the next generation of cardiovascular digital twins, with particular attention to advances in computational methodologies, intelligent automation, and their translation into practical applications. Emerging technologies, including AI agents, physics-informed learning, reduced-order modelling, and autonomous simulation workflows, open new possibilities for improving the accessibility, adaptability, and computational efficiency of digital twin frameworks. Alongside these technological advances, growing opportunities for commercialisation, academic spin-outs, and industry partnerships highlight the importance of developing viable pathways from research innovations to deployable healthcare technologies.

Despite these advances, important challenges remain in ensuring physiological accuracy, model reliability, interpretability, clinical validation, and scalability. Successful translation also requires consideration of regulatory requirements, intellectual property, commercial viability, and sustainable business models. The mini-symposium seeks to bring together researchers, clinicians, engineers, entrepreneurs, and industry representatives to share recent developments, examine emerging challenges, and encourage interdisciplinary collaborations that advance cardiovascular digital twins from research frameworks towards real-world clinical and commercial applications.

Main Features of the Mini-symposium:
– Exploring emerging developments in cardiovascular digital twins, building upon the research and discussions presented at CMBE 2026 in Kobe.
– Integrating computational biomechanics, artificial intelligence, and multimodal clinical data to create adaptive, patient-specific digital twins.
– Investigating the role of AI agents and agentic frameworks in automating simulation workflows, coordinating computational models, and enabling intelligent interaction with digital twins.
– Advancing multiscale and multiphysics modelling, linking cellular and tissue-level processes with whole-organ and systemic cardiovascular dynamics.
– Highlighting computational acceleration through reduced-order modelling, surrogate models, physics-informed neural networks, and high-performance computing.
– Exploring clinical applications, including personalised diagnosis, disease progression monitoring, treatment optimisation, and virtual clinical trials.
– Addressing verification, validation, uncertainty quantification, and regulatory considerations for reliable clinical and industrial translation.
– Exploring commercialisation opportunities, entrepreneurial initiatives, and academia-industry partnerships to translate digital twin research into viable healthcare products and services.
– Encouraging collaboration between computational researchers, clinicians, AI specialists, entrepreneurs, and industry partners to develop scalable and interoperable digital twin technologies.

SCOPE AND PURPOSE
Topics include, but are not limited to:
– Multiscale and multiphysics modelling of cardiac and vascular systems, including haemodynamics, electromechanics, and fluid–structure interactions.
– Artificial intelligence and machine learning for patient-specific parameter estimation, model calibration, inverse problems, and predictive simulations.
– AI agents and multi-agent systems for digital twins, including autonomous model orchestration, simulation management, data interpretation, and decision-support workflows.
– Integration of large language models and agentic AI with physics-based simulations for natural-language interaction, automated scenario exploration, and intelligent computational workflows.
– Reduced-order models, surrogate modelling, physics-informed learning, and GPU-accelerated computing for real-time and large-scale applications.
– Data assimilation and integration of medical imaging, wearable technologies, electronic health records, and physiological monitoring systems.
– Adaptive and continuously updated cardiovascular digital twins for longitudinal monitoring and prediction of disease progression.
– Verification, validation, sensitivity analysis, uncertainty quantification, and explainability of AI-integrated digital twin frameworks.
– Virtual clinical trials, in-silico intervention planning, medical device optimisation, and personalised treatment strategies.
– Human-in-the-loop approaches, trustworthy AI, and safety considerations for intelligent and agent-driven digital twin systems.
– Interoperability, data governance, regulatory frameworks, and computational infrastructure for clinical and industrial deployment.
– Commercialisation and entrepreneurship in cardiovascular digital twins, including academic spin-outs, intellectual property, licensing, industry partnerships, business models, and investment opportunities.
– Clinical and industrial case studies demonstrating practical implementation, validation, and translational potential of cardiovascular digital twins.

Organisers: Rahul Bale, RIKEN-CCS, Japan; Makoto Tsubokura*, RIKEN-CCS. The graduate school of system informatics, Kobe University, Japan (Email: mtsubo@riken.jp); Yuichiro Suda, Kyushu University, Japan; Masashi Yamakawa, Kyoto Institute of Technology.

Keywords: Airflow and aerosol transport, Inhalation exposure, Respiratory deposition, Indoor ventilation.

Relevant Conference Topics: Artificial intelligence (AI) and machine learning, Numerical methods, High-performance computing, Respiratory systems

Mini-symposium details:

Computational fluid and particle dynamics (CFPD) provides a framework for investigating airflow and aerosol transport in indoor environments and the human respiratory tract. Connecting these domains enables the study of how ventilation conditions, aerosol characteristics, and human breathing influence inhalation exposure and particle deposition. This multiscale perspective links environmental transport processes with respiratory physiology, supporting the assessment of inhaled and deposited doses and their relevance to respiratory health and transmission of airborne diseases.

This minisymposium aims to bring together researchers in computational fluid dynamics, aerosol science, building ventilation, and respiratory biomechanics to discuss advances in multiscale airflow and aerosol transport. Contributions are invited on indoor dispersion, transport within the breathing zone, inhalation and airway deposition, and coupled environmental–respiratory modelling. Topics also include advanced numerical methods, high-performance computing, data-driven approaches, experimental validation, and uncertainty quantification. Particular emphasis will be placed on connecting computational predictions with biologically relevant measures of exposure and dose, and on applications that inform ventilation design, exposure mitigation, and respiratory health.

Organisers: Michael Sacks*, Oden Institute and the Department of Biomedical Engineering, University of Texas at Austin, USA (Email: msacks@oden.utexas.edu); David Nordsletten, Department of Biomedical Engineering, University of Michigan, USA.

Keywords: Cardiac Modeling, Cardiac Mechanics, Scientific Machine Learning, clinical application.

Relevant Conference Topics: Cardiovascular modelling, Computational medicine, Artificial intelligence (AI) and machine learning, Biofluid and biosolid mechanics

Mini-symposium details:

One goal of Scientific Machine Learning (SciML) is to advance traditional scientific computing frameworks with modern machine learning based tools. This includes extending established approaches, such as the finite element method that simulate normal and diseased cardiac function, to be capable very rapid execution times for real time clinical simulations. The recent boom in machine learning (ML) and artificial intelligence (AI) in general has opened new horizons in computational mechanics of the heart through multiple innovations, e.g.: enhancing or replacing the finite element method, isogeometric analysis to handle complex cardiac geometry efficiently, and finite volume methods that utilize artificial neural networks, Gaussian processes, and other ML architectures. In addition, data-driven constitutive modeling of myocardial behavior, including automatic satisfaction of reasonable constraints such as polyconvexity, or posing of inverse problems for identification of model parameters by by directly learning the inverse map. These advances can be applied to the heart to solve the inverse problem of cardiac remodeling in disease from large animal data, and the calibrated model can be used to design better expansion protocols that produce the desired shape of newly grown skin flaps. Another important application is the use of ML surrogates of myocardium trained on a large number of simulations spanning broad range of material parameters, loading and boundary conditions, enabling prediction of cardiac biomechanics for patient specific cases in clinically-relevant timeframes impossible with traditional high-fidelity physics solvers. In the longer-term, integration with circulatory models, accurate electromechanics, and disease modeling will need to be addressed.

This mini-symposium seeks both: i) fundamental advances in ML and AI approach for cardiac modeling at all scales analogous to the innovations listed above, ii) develop of application pipelines for biomedical problems enabled by ML and AI. We will also invite novel programing approaches that allow for the required flexibility to extend to more realistic cardiac models while maintaining the ease of use needed to make SciML more accessible to the broader scientific community.

Share This Page, Choose Your Platform!